FindTrial
Sign In

Granulocyte-colony stimulating factor

DRUG6 trials

Sponsors

Masonic Cancer Center, University of Minnesota, Barts & The London NHS Trust, Polish Lymphoma Research Group, Washington University School of Medicine, H. Lee Moffitt Cancer Center and Research Institute

Conditions

Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaChronic Ischaemic Heart FailureDiffuse Large B Cell LymphomaMultiple MyelomaMyelodysplastic SyndromePoor Graft Function

Early Phase 1

Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)
CompletedNCT02851056
H. Lee Moffitt Cancer Center and Research InstituteMultiple Myeloma
Start: 2016-09-27End: 2018-08-09Updated: 2022-11-14

Phase 1

Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation
TerminatedNCT02750254
Washington University School of MedicineAcute Lymphocytic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
Start: 2016-06-27End: 2020-10-14Updated: 2020-10-20

Phase 2

Autologous Transplant for Multiple Myeloma
CompletedNCT00177047
Masonic Cancer Center, University of MinnesotaMultiple Myeloma
Start: 2004-04-20End: 2020-08-01Updated: 2021-11-09
Bone Marrow Derived Adult Stem Cells for Chronic Heart Failure
CompletedNCT00747708
Barts & The London NHS TrustChronic Ischaemic Heart Failure
Start: 2005-08-31End: 2013-05-31Updated: 2013-10-09
Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients
CompletedNCT01481272
Polish Lymphoma Research GroupDiffuse Large B Cell Lymphoma
Start: 2011-11-30End: 2018-12-31Updated: 2021-12-27

Phase 3

Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT
Not yet recruitingNCT05669079
The First Affiliated Hospital of Soochow UniversityPoor Graft Function
Start: 2023-08-01End: 2026-11-01Target: 100Updated: 2023-06-09

Related Papers

Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma
Clinical Cancer Research2023-09-2215 citations
Advances in Dendritic Cell-Based Therapies for Hematologic Malignancies
Oncology Times2020-04-10
OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R‐CHOP AND WERE NOT CANDIDATES FOR HIGH‐DOSE THERAPY AND ASCT ‐ PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG‐8)
Hematological Oncology2019-06-01
Clinical feasibility study to detect angiogenesis following bone marrow stem cell transplantation in chronic ischaemic heart failure.
2014-08-0118 citations